EPO-derived peptide (investigational)
An investigational peptide derived from erythropoietin, studied for neuropathic pain and inflammation.
Early clinical research in specific conditions; not established or approved.
Investigational; outside trials it is unregulated with uncertain quality.
Investigational — not approved as a medicine in Australia.
No lawful consumer supply. Access would be via an approved clinical trial.
This entry is general information about ARA-290 (Cibinetide), not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.
This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.